MEDIAN DIAGNOSTICS  ·  VETERINARY INTELLIGENCE

PEDV
INSIGHTS

Porcine Epidemic Diarrhea — Global Intelligence Report

March  ·  2026  ·  FOR VETERINARY PROFESSIONALS

◆  Severe 2026 Global Resurgence  ◆  SHIC: US Positivity Hits 14.0%  
◆  Only 21.2% of Sows Protected  ◆  Neonatal Mortality Approaching 100%

SITUATION REPORT

PEDV Is Back — and Bigger Than the Numbers Show

Official statistics capture only a fraction of real-world outbreaks. A paradigm shift — from eradication to active management — is now underway.

100%

Neonatal Piglet
Mortality Rate

21.2%

Sows with
protective antibodies

14.0%

US Sow Farm Positivity
(Highest Since 2022)

According to the 2026 Korea Swine Veterinary Forum, the swine industry is facing a severe resurgence of PEDV driven by its persistent 2-year epidemic cycle. While past official counts noted 249 outbreaks, recent 2025/2026 academic publications (e.g., Frontiers in Microbiology, 2025) emphasize that the lack of effective vaccines against circulating strains continues to cause mortality rates approaching 100% in neonatal piglets. A nationwide government antibody survey revealed that only 21.2% of breeding sows maintain protective neutralizing antibodies, leaving the vast majority of herds effectively unshielded.

⚠  The "Hidden Infection" Problem

Official Statistics Undercount the Real Burden

Veterinary experts have repeatedly stressed that the actual field impact of PED is far more severe than official case counts suggest. Because PEDV is a notifiable disease, confirmed diagnosis triggers movement restrictions — discouraging voluntary farm reporting and creating a large pool of "hidden infections."

To combat this, the industry is shifting from an eradication to a management paradigm. Experts advocate for voluntary, industry-led surveillance networks where farms and veterinarians share diagnostic data proactively. Active immunity monitoring, rather than reactive reporting, is now the critical foundation of PED control.

SHIC Alert · United States · 2026

PEDV Surges to Highest US Levels Since 2022

According to the Swine Health Information Center (SHIC) SDRS reports, PEDV case positivity has climbed significantly above expected seasonal ranges. Adult and sow farm positivity reached 14.0% — the highest recorded level since the major outbreaks of 2022. This alarming data underscores that current biosecurity and vaccination protocols alone are struggling to contain the virus, making proactive mucosal immunity monitoring more critical than ever before.

◆   ◆   ◆

IMMUNOLOGY FOCUS

Two Pathways. Two Antibodies.
One Critical Gap in Monitoring.

Understanding why IgG alone is not enough — and why IgA is the key to protecting newborn piglets.

Maternal Antibody Transfer from Sow to Piglet — Median Diagnostics

Fig. 1 · Median Diagnostics — IgG (Systemic Passive) & sIgA (Local Lactogenic) Antibody Transfer Pathways

IM Vaccination Route

IgG — Systemic Immunity

IM vaccine → Regional LN → IgG plasmablast → Blood → FcRn receptor → Colostrum → Piglet gut absorption → Systemic passive immunity

Oral Vaccination Route

sIgA — Mucosal Immunity

Oral vaccine → GALT (Peyer's patch) → IgA plasmablast → Gut-Mammary Axis homing → pIgR → sIgA in milk → Piglet intestinal mucosa → Local lactogenic immunity

Clinical Insight

A sow with high serum IgG may still have inadequate sIgA in her milk — leaving nursing piglets vulnerable to intestinal PEDV despite appearing "vaccinated." These two antibody classes must be monitored independently. sIgA persists throughout lactation (21 days), while IgG drops below protective threshold from Day 5 post-farrowing — making IgA the dominant and sustained shield for nursing piglets.

◆   ◆   ◆

MEDIAN RESEARCH  ·  PEER-REVIEWED

Effects of porcine epidemic diarrhoea virus vaccination timing and route of administration on colostrum antibody levels and prevention of diarrhoea in piglets on a pig farm with porcine epidemic diarrhoea

Kang BK, Min DS, Kim DI, et al. Journal of Virological Methods 342 (2026) 115360

MEDIAN Diagnostics, Chuncheon, Korea  ·  Published: January 31, 2026  ·  DOI: 10.1016/j.jviromet.2026.115360

This field study evaluated five PEDV vaccination programs in a 400-sow farm (Iksan, Korea) with confirmed PEDV genotype 2b infection, measuring colostrum IgA, IgG, and virus neutralization (VN) antibody profiles using Median Diagnostics' VDPro® PEDV IgA ELISA and VDPro® PEDV IgG ELISA kits, alongside the VDx® PEDV qRT-PCR and VDRG® PEDV Ag Rapid Kit for initial diagnosis.

Vaccination Group IgA S/P
(mean)
IgG S/P
(mean)
VNT
(log₂)
Control (unvaccinated) 2.39 2.09 5.82
1K1L (IM+oral, 1wk before) 3.60 ↑* 2.12 5.60
2K2L (IM+oral, 2wks before) 2.59 (ns) 2.22 6.20
3K1L (IM×1 at 3wks + oral at 1wk) 3.41 ↑* 2.25 6.17
5K3K1L (IM×2 + oral at 1wk) ★ 4.27 ↑** 2.45 7.00 ↑**

* p<0.01   ** p<0.0001 vs. control. ns = not significant. ★ = optimal program

Key Findings

1.

IgA, not IgG, predicts clinical protection. Diarrhoea and growth retardation disappeared only in the 3K1L and 5K3K1L groups — those with significantly elevated colostrum IgA. Average weaning weight improved from 4.1 kg to 7.0 kg after optimal vaccination. IgG levels showed no meaningful difference across groups.

2.

Timing of oral vaccine is critical: 1 week before farrowing is the immunological window. Oral live-attenuated vaccine administered 1 week before farrowing consistently produced higher IgA than the same vaccine given 2 weeks prior — because IgA plasmablast homing to the mammary gland is maximized by oestrogen/progesterone hormonal shifts and peak CCL28/CXCL12 chemokine expression in the final week of gestation.

3.

IgA persists throughout 21 days of lactation; IgG collapses from Day 5. Longitudinal sampling in 3K1L sows confirmed that colostrum IgA S/P remained at ~3.0 across the entire lactation period, while IgG fell below the positive threshold (S/P <0.5) from Day 5 onward — making sIgA in milk the only sustained passive immune shield for nursing piglets.

4.

Virus-neutralizing antibodies (VNT) complement but do not replace IgA monitoring. VNT was highest in the 5K3K1L group (log₂ = 7.0) and correlated with repeated vaccination, but previous literature shows VNT is only weakly correlated with mucosal IgA. VNT serves as a useful supplementary indicator — not a substitute for direct IgA measurement in colostrum and milk.

Study Conclusion — Kang et al., 2026

"Oral administration of the live attenuated vaccine approximately 1 week before farrowing elicited the strongest IgA-mediated mucosal response. IgG levels showed no marked differences among the vaccination timings, and IgA persisted during the lactation period, highlighting the importance of colostrum IgA in protective immunity. The timing and administration route of PEDV vaccination are critical for establishing maternal immunity in piglets."

Read Full Paper on ScienceDirect

◆   ◆   ◆

WHY DIAGNOSTICS MATTER

The "Manage, Don't Eradicate" Era Demands Active Monitoring

As the Korean and global swine industries shift from outbreak-triggered response to proactive surveillance, three diagnostic pillars define a sound PEDV management program:

① Detect Active Infection — Immediately

Every hour without a confirmed diagnosis is time the virus spreads to neighboring pens. Pen-side antigen rapid testing eliminates the diagnostic delay — enabling same-day isolation, movement control, and farm-level response before spread becomes catastrophic.

② Monitor Sow Immunity — Before Farrowing

The Kang et al. (2026) study demonstrates that colostrum IgA is the decisive protective factor — but it is invisible without testing. Routine pre-farrowing IgA and IgG ELISA screening reveals immunity gaps in time to adjust vaccination timing, preventing the next cycle of neonatal diarrhea and productivity loss.

③ Confirm and Trace — with Molecular Precision

qRT-PCR provides the quantitative viral load data needed for outbreak severity assessment, genotyping, and epidemiological surveillance — the backbone of any voluntary monitoring network modeled on the MSHMP.

DIAGNOSTIC SOLUTIONS

MEDIAN Diagnostics PEDV Portfolio

Five validated kits — covering every stage from pen-side detection to laboratory confirmation.

VDRG PEDV Ag Rapid Kit

Rapid Detection  ·  On-Farm Point-of-Care

VDRG® PEDV Ag Rapid kit

Rapid chromatographic immunoassay for on-site PEDV antigen detection. Delivers reliable results in just 10 minutes without laboratory equipment. Validated in the Kang et al. (2026) field study.

Target

PEDV N protein

Test time

10 minutes

Specimen

Pig feces

Cat. No. PS-PED-11  |  10 Tests/Box  |  APQA Approved

View Product →
VDPro PEDV IgA ELISA Kit

ELISA  ·  Mucosal Immunity

VDPro® PEDV IgA ELISA Kit

Indirect ELISA to quantify PEDV-specific IgA. Accurately measures mucosal lactogenic immunity, proven by Kang et al. (2026) to be the most critical predictor of piglet protection.

Target

Anti-PEDV IgA

Method

Indirect ELISA

Specimen

Serum / Milk

Cat. No. ES-PED-01  |  192 or 480 Tests/Kit  |  Export only

View Product →
VDPro PEDV IgG ELISA Kit

ELISA  ·  Systemic Immunity

VDPro® PEDV IgG ELISA Kit

Indirect ELISA to monitor PEDV-specific IgG in sow serum and colostrum. Essential for assessing systemic humoral immune responses and evaluating overall herd vaccination compliance.

Target

Anti-PEDV IgG

Method

Indirect ELISA

Specimen

Serum / Colostrum

Cat. No. ES-PED-02  |  192 or 480 Tests/Kit  |  Export only

View Product →
VDx PEDV qRT-PCR

Real-Time RT-PCR  ·  Genogrouping

VDx® PEDV qRT-PCR

Multiplex real-time RT-PCR for the simultaneous detection and differentiation of PEDV Genogroup 1 and Genogroup 2 strains. Delivers definitive confirmatory diagnosis and reliable strain tracking.

Target

PEDV G1 & G2

Method

Multiplex qRT-PCR

Specimen

Feces / Tissue

Cat. No. NS-PED-31  |  96 Tests/Box  |  APQA Approved

View Product →
VDx PEDV qRT-PCR Ver 2.0

Real-Time RT-PCR  ·  N Gene Target

VDx® PEDV qRT-PCR Ver 2.0

NEW

Advanced TaqMan-based real-time RT-PCR targeting the PEDV N gene. Features dual Internal Positive Controls (Endo & Exo) for unmatched diagnostic reliability. Used for definitive diagnosis in Kang et al. (2026).

Target gene

N gene

IPC

Dual (Endo+Exo)

Specimen

Blood/Serum/Feces

Cat. No. NS-PED-32  |  96 Tests/Kit  |  Export only

View Product →

The path forward begins with a test.

As the swine industry embraces active surveillance over reactive reporting, Median's five-kit PEDV portfolio provides the scientific foundation for a complete on-farm and laboratory-level monitoring program — validated by peer-reviewed field research published in the Journal of Virological Methods (2026).

MEDIAN Diagnostics

Head Office: 878, Sunhwan-daero, Dongnae-myeon, Chuncheon-si, Gangwon-do, Korea
Tel. +82-33-244-0100  |  Fax. +82-33-244-4634  |  E-mail. median@mediandx.com

Seoul Office: C-1114, SK V1 GL Metrocity, 128, Beobwon-ro, Songpa-gu, Seoul, Korea
Tel. +82-2-3401-0110  |  Fax. +82-2-3401-0112

Website LinkedIn YouTube Instagram
@

WEBSITE

LINKEDIN

YOUTUBE

INSTAGRAM

★ NEW

THREADS

★ NEW

© 2026 Median Diagnostics · All rights reserved · For veterinary professionals